Thomas Lechmere
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 detection and testing 1
-
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 1
- Acute Myeloid Leukemia Research 1
- Co-authors
- Katie J. Doores (10 shared papers)Carl Graham (9 shared papers)Michael H. Malim (8 shared papers)Timothy Tree (3 shared papers)Sam Norton (2 shared papers)Clara Domingo‐Vila (3 shared papers)Satveer K. Mahil (2 shared papers)Freya Meynell (2 shared papers)
- Journals
- mBio (2 papers)Cell Reports (1 paper)Leukemia (1 paper)PLoS Pathogens (1 paper)The Lancet Rheumatology (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Thomas Lechmere
10 papers receiving 216 citations
Peers
Comparison fields: 5 of 36
- Infectious Diseases 135
- Immunology 53
- Rheumatology 21
- Animal Science and Zoology 15
- Hematology 15
Countries citing papers authored by Thomas Lechmere
This map shows the geographic impact of Thomas Lechmere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lechmere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lechmere more than expected).
Fields of papers citing papers by Thomas Lechmere
This network shows the impact of papers produced by Thomas Lechmere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lechmere. The network helps show where Thomas Lechmere may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Lechmere, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 104 | |
| 2 | Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study | 2022 | 37 |
| 3 | 2021 | 31 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 5 | |
| 8 | 2023 | 5 | |
| 9 | 2021 | 1 | |
| 10 | 2022 | 1 |
About Thomas Lechmere
Thomas Lechmere is a scholar working on Infectious Diseases, Hematology, Genetics, Oncology and Immunology, having authored 10 papers that have together received 220 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers), Hematopoietic Stem Cell Transplantation (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Infection Control and Ventilation (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Acute Myeloid Leukemia Research (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Infectious Diseases (135 citations), Immunology (53 citations), Rheumatology (21 citations), Animal Science and Zoology (15 citations) and Hematology (15 citations). Thomas Lechmere has collaborated with scholars based in United Kingdom. Frequent co-authors include Katie J. Doores, Carl Graham, Michael H. Malim, Timothy Tree, Sam Norton, Clara Domingo‐Vila, Satveer K. Mahil, Freya Meynell, Katie Bechman and Antony Raharja. Their work appears in journals such as mBio, Cell Reports, Leukemia, PLoS Pathogens and The Lancet Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.